Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 8 (August)

1. Validity of melanoma diagnosis in a community-based screening program.
   Am J Epidemiol, 164(4): 385-90. [Abstract] [Full-text]
2. Intraparotid sentinel lymph node biopsy for head and neck melanoma.
   Laryngoscope, 116(8): 1461-4. [Abstract] [Full-text]
3. Expression of inappropriate cadherins by epithelial tumor cells promotes endocytosis and degradation of E-cadherin via competition for p120(ctn).
   Oncogene, 25(33): 4595-604. [Abstract] [Full-text]
4. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
   Am J Clin Oncol, 29(4): 352-60. [Abstract] [Full-text]
5. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.
   Br J Cancer, 95(4): 548-53. [Abstract] [Full-text]
6. Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus?
   J Am Acad Dermatol, 55(3): 460-6. [Abstract] [Full-text]
7. Optical coherence tomography for the characterization of basal cell carcinoma in vivo: a pilot study.
   J Am Acad Dermatol, 55(3): 408-12. [Abstract] [Full-text]
8. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
   Br J Cancer, 95(4): 496-505. [Abstract] [Full-text]
9. Pathways to the development of melanoma: a complex issue.
   J Invest Dermatol, 126(9): 1932-3. [Abstract] [Full-text]
10. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
    J Invest Dermatol, 126(9): 2106-10. [Abstract] [Full-text]
11. High incidence of second basal cell skin cancers.
    Int J Cancer, 119(6): 1505-7. [Abstract] [Full-text]
12. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
    Int J Cancer, 119(6): 1312-5. [Abstract] [Full-text]
13. Utility of the mouse dermal promotion assay in comparing the tumorigenic potential of cigarette mainstream smoke.
    Food Chem Toxicol, 44(10): 1699-706. [Abstract] [Full-text]
14. Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas.
    Leukemia, 20(9): 1593-601. [Abstract] [Full-text]
15. Frequent positive staining with NKI/C3 in normal and neoplastic tissues limits its usefulness in the diagnosis of cellular neurothekeoma.
    Am J Clin Pathol, 126(4): 554-63. [Abstract] [Full-text]
16. Melanocortin 1 receptor variants and skin cancer risk.
    Int J Cancer, 119(8): 1976-84. [Abstract] [Full-text]
17. Food intake and risk of squamous cell carcinoma of the skin in a community: the Nambour skin cancer cohort study.
    Int J Cancer, 119(8): 1953-60. [Abstract] [Full-text]
18. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    J Clin Oncol, 24(25): 4196-201. [Abstract] [Full-text]
19. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma.
    J Surg Oncol, 94(4): 287-92. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.